3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
2
Not yet recruiting
2
Completed
2
Unknown
1
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
17
Gynecologic
2
Gastrointestinal
2
Other solid neoplasm
1
Other hematologic neoplasm
1
Head & Neck
1
Conditions
Recurrence
1
Ovarian Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Paclitaxel
79
Carboplatin
66
pembrolizumab
61
Bevacizumab
56
Cisplatin
48
Specimen Handling
29
Drug Therapy
26
Blood Specimen Collection
24
Cyclophosphamide
20
olaparib
19
Taxes
17
Magnetic Resonance Spectroscopy
16
Letrozole
16
Gemcitabine
16
Biopsy
16
liposomal doxorubicin
15
niraparib
14
fludarabine
14
Brachytherapy
14
Radiotherapy
13
abemaciclib
12
Topotecan
11
Nivolumab
11
Injections
11
Doxorubicin
11
lenvatinib
10
Fluorouracil
10
atezolizumab
9
Surveys and Questionnaires
9
Standard of Care
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Platinum Compounds
×
Gynecologic
×
Clear all
NCT07340164
2026-04-20
TROY
Yonsei University
Phase 2
Recruiting
116 enrolled
NCT03954171
2025-11-18
PlatinOv
Institut Claudius Regaud
Phase NA
Recruiting
600 enrolled